These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6582525)

  • 21. Dexamethasone suppression test and subcategories of DSM-III major depression.
    Kitamura T; Shima S; Shikano T; Kano S; Asai M; Itoh H
    Psychopathology; 1985; 18(4):198-200. PubMed ID: 4089118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dexamethasone suppression test and depressive symptoms in early and late withdrawal from alcohol.
    Ravi SD; Dorus W; Park YN; Collins MC; Reid RW; Borge GF
    Am J Psychiatry; 1984 Nov; 141(11):1445-8. PubMed ID: 6496789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone suppression test status and severity of depression.
    Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
    Biol Psychiatry; 1988 Oct; 24(6):693-6. PubMed ID: 3167151
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the ACTH suppression test and dexamethasone suppression test in depressed patients.
    Demisch K; Demisch L; Bochnik HJ; Schulz F
    Am J Psychiatry; 1983 Nov; 140(11):1511-2. PubMed ID: 6312817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
    Larsen JK; Bjørum N; Kirkegaard C; Aggernaes H; Krog-Meyer I; Lund-Laursen AM; Mikkelsen PL
    Acta Psychiatr Scand; 1985 May; 71(5):499-505. PubMed ID: 3925727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An elaborate description of the symptomatology of patients with Research Diagnostic Criteria endogenous depression.
    de Jonghe F; Ameling E; Assies J
    J Nerv Ment Dis; 1988 Aug; 176(8):475-9. PubMed ID: 3404139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone suppression in dementia, depression, and normal aging.
    Georgotas A; McCue RE; Kim OM; Hapworth WE; Reisberg B; Stoll PM; Sinaiko E; Fanelli C; Stokes PE
    Am J Psychiatry; 1986 Apr; 143(4):452-6. PubMed ID: 3953888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic validity of the dexamethasone suppression test: results of a six-month prospective follow-up.
    Zimmerman M; Coryell W; Pfohl B
    Am J Psychiatry; 1987 Feb; 144(2):212-4. PubMed ID: 3812791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dexamethasone suppression test during recurrent major depressive episodes.
    Yerevanian BI; Privitera MR; Milanese E; Sagi EA; Russotto JC
    Biol Psychiatry; 1984 Mar; 19(3):407-12. PubMed ID: 6722230
    [No Abstract]   [Full Text] [Related]  

  • 31. Dexamethasone suppression test and primary obsessional compulsive disorder.
    Vallejo J; Olivares J; Marcos T; Martínez-Osaba MJ; Ribera F; Bulbena A
    Compr Psychiatry; 1988; 29(5):498-502. PubMed ID: 3180759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity?
    Miller KB; Nelson JC
    Arch Gen Psychiatry; 1987 Sep; 44(9):769-74. PubMed ID: 3632250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.
    Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
    Acta Psychiatr Scand; 1990 Apr; 81(4):364-71. PubMed ID: 2343764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memory disturbances and dexamethasone suppression test in major depression.
    Wauthy J; Ansseau M; von Frenckell R; Mormont C; Legros JJ
    Biol Psychiatry; 1991 Oct; 30(7):736-8. PubMed ID: 1958771
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparison of masked and endogenous depression using psychometric scales, endocrinological markers and pharmacological responses. Masked depression versus endogenous depression].
    Pinard G; Desmarais PA; Cormier H; Dymetryszyn R; Tétreault L
    Encephale; 1986; 12(3):99-103. PubMed ID: 3095093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF; Hunt G; Kerr K; Caterson I
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taking the measure of anxiety and depression. Validity of the reconstructed Hamilton scales.
    Riskind JH; Beck AT; Brown G; Steer RA
    J Nerv Ment Dis; 1987 Aug; 175(8):474-9. PubMed ID: 3625186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone suppression in depressed elderly outpatients.
    Allen RE; Pitts FN
    J Clin Psychiatry; 1984 Sep; 45(9):397-8. PubMed ID: 6469926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome.
    Klein HE; Bender W; Mayr H; Niederschweiberer A; Schmauss M
    Br J Psychiatry; 1984 Dec; 145():591-9. PubMed ID: 6509268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone suppression test in depressive stroke patients.
    Dam H; Pedersen HE; Damkjaer M; Ahlgren P
    Acta Neurol Scand; 1991 Jul; 84(1):14-7. PubMed ID: 1927256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.